International Medical Faculty
Facial Plastic Surgery · Myomodulation · Metabolic Peels · Artificial Intelligence
Dr Alain Tenenbaum
MD, PhD, DSc (Hon.)
Facial plastic surgeon, researcher, author and international medical educator. Founder of Myomodulation, developer of three-dimensional isovolumetric chemical myoplasty, inventor of Endopeel®, and developer of metabolic chemical peel protocols. Dr Alain Tenenbaum is also an expert in artificial intelligence applied to aesthetic medicine, medical communication and high-end digital medical ecosystems.
Myomodulation Chemical Myoplasty Metabolic Peels Artificial Intelligence
Professional Overview
- Facial plastic surgeon, researcher, author and international medical educator.
- Founder and Medical Director of Myomodulation.
- Founder of three-dimensional isovolumetric chemical myoplasty for functional and aesthetic muscle modulation.
- Inventor of Endopeel® and developer of metabolic chemical peel protocols.
- International expert in facial aesthetics, body contouring, chemical peeling and complication management.
- Expert in artificial intelligence applied to aesthetic medicine, medical education and medical communication.
- Expert in digital medical strategy, premium medical websites, applications and high-end medical web ecosystems.
- Former Swiss National Delegate to the European Academy of Facial Plastic Surgery.
- Former Webmaster of EAFPS.org.
- Former Webmaster for the Aesthetic Medicine Section of the Royal Society of Medicine, London.
Academic Degrees & Distinctions
- Doctor of Medicine – MD.
- Doctor PhD – PhD.
- Doctor of Science – DSc.
- Doctor Honoris Causa in Sciences – Henan University, China.
- Former Associate Professor of Plastic Surgery – Zhengzhou, China.
- Former Associate Professor of Medical Informatics – Faculty of Medicine of Nancy, France.
- Silver Medal – Faculty of Medicine, University of Paris.
Medical & Scientific Training
- ENT and Facial Plastic, Reconstructive & Cosmetic Surgery – Paris.
- Aerospace and Aviation Medicine.
- Biological Physical Chemistry.
- Biophysics.
- Biomathematics and Biostatistics.
Scientific Innovations & Contributions
- Founder of Myomodulation.
- Developer of three-dimensional isovolumetric chemical myoplasty.
- Developer of non-surgical functional muscle projection and body-contouring protocols.
- Inventor of Endopeel®.
- Developer of metabolic chemical peel protocols.
- International lecturer in chemical peels, facial aesthetics, body contouring and functional muscle modulation.
- International authority on complications associated with fillers and implants.
Leadership & International Roles
- University Lecturer in Chemical Peels and Myomodulation – University Diploma in Aesthetic Medicine, Paris.
- Former President – SACDAM.
- Former President – International Peelings Society.
- Former Swiss National Delegate – European Academy of Facial Plastic Surgery.
- Former Webmaster – EAFPS.org.
- Former Webmaster – Aesthetic Medicine Section, Royal Society of Medicine, London.
- Member of the FMH, EAFPS and international scientific societies.
Current Medical, Scientific & AI Expertise
Myomodulation
Functional muscle modulation and three-dimensional isovolumetric chemical myoplasty.
Body Contouring
Male and female non-surgical gluteoplasty and isovolumetric muscle projection.
Metabolic Peels
Metabolic chemical peeling, epidermal integrity and skin barrier preservation.
Complication Management
Prevention and management of complications associated with fillers, implants and aesthetic procedures.
Artificial Intelligence
AI strategy, AI-assisted medical communication, knowledge architecture and intelligent medical digital ecosystems.
Medical Digital Strategy
Medical SEO, website architecture, medical applications, premium domains and high-end clinical web ecosystems.
Current positioning: Myomodulation represents Dr Alain Tenenbaum’s principal contemporary scientific and clinical platform. Endopeel® remains referenced as an original invention and an important historical contribution to his professional and scientific career.
